VT News
David Legwand

David Legwand

Ask VT AI
View News Summary
  • Bears' Caleb Williams to skip preseason opener, focus on joint practices for evaluation and development.
  • Gilead Sciences reports strong Q2 2025 results, raises full-year guidance, and sees its stock surge to a 7-year high amid optimism about its strategy and pipeline momentum.
  • Fortescue secures landmark $2B yuan loan in China, deepening ties and advancing green agenda.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Bears' Caleb Williams to skip preseason opener, focus on joint practices for evaluation and development.
  • Gilead Sciences reports strong Q2 2025 results, raises full-year guidance, and sees its stock surge to a 7-year high amid optimism about its strategy and pipeline momentum.
  • Fortescue secures landmark $2B yuan loan in China, deepening ties and advancing green agenda.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from David Legwand

Top Topics

Trending in U.S.

World

Sport